QTRX

Quanterix (QTRX)

About Quanterix (QTRX)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Details

Daily high
$7.54
Daily low
$7.25
Price at open
$7.32
52 Week High
$12.41
52 Week Low
$4.05
Market cap
346.1M
Dividend yield
0.00%
Volume
532,826
Avg. volume
857,217
P/E ratio
-3.18

Quanterix News

Details

Daily high
$7.54
Daily low
$7.25
Price at open
$7.32
52 Week High
$12.41
52 Week Low
$4.05
Market cap
346.1M
Dividend yield
0.00%
Volume
532,826
Avg. volume
857,217
P/E ratio
-3.18